From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver Pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and business process infrastructure for market access and therapy commercialization.
Solutions overview
IntegriChain delivers the life science industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
To ensure you get the most out of your access and commercialization investment, IntegriChain provides a complete set of professional Advisory and Systems Integration Services designed to further your business and success.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the life sciences industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, Market Access experts, analysts, technologies, and advisory professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Registration is now open for this year’s conference taking place October 17-19, 2022, in Baltimore.
Register now
We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments
How we do it
Uniting financial, operational, and commercial data to support therapy access
Learn more
Contracting, pricing, data aggregation and refinement, and gross-to-net to ensure Day-1 readiness
Learn how
Groundbreaking data and analytics that identify and resolve barriers to patient initiation and adherence faster
Network, benchmark and share with your peers in this private, anonymous network of business and financial professionals
Join our online community now!
More than 400 pharmaceutical manufacturers – including all top-30 – rely on IntegriChain’s ICyte Platform to orchestrate commercial and government payer contracting, patient services, and distribution channels.
ICyte is the first and only platform that unites the financial, operational, and commercial data sets required to support therapy access in the era of specialty and precision medicine. With ICyte, pharmaceutical and life sciences innovators are digitalizing labor-intensive processes – freeing up their best talent to identify and resolve coverage and availability hurdles and to manage pricing and forecasting complexity.
Optimize your drug commercialization and meet contractual obligations
Learn More
Improve patient initiation and adherence
360° visibility to your product in the channel
Bringing control and automation to high-risk, spreadsheet-driven processes
World-class technology powering market-leading access analytics, applications, and managed services.
Learn more about ICyte
200+ Life Sciences manufacturers of all size and complexity rely on our Managed Services for rebate adjudication, GP, and GTN
35K+ Medicaid claims processed every quarter by our Managed Services team
$3B+ Industry rebates processed through ICyte
63% of all therapy launches supported by ICyte and IntegriChain
200+ Managed Services professionals including >55% with 10+ years of market access experience
Access Insights Conference 2022 October 17-19 Inner Harbor, Baltimore
Register Now
Revenue Analytics CollaborativeCheck out our online community.
Join Today
Advisory Market Updates
Regulatory Updates for Life Sciences Manufacturers
Read More
